The rapid and accurate diagnosis of patients with minimally invasive procedures was once only found in science fiction. However, the discovery of extracellular vesicles (EVs) and their near ubiquity in body fluids, coupled with the advent of inexpensive next generation sequencing techniques and EV purification protocols, promises to make science fiction a reality. Purifying and sequencing the RNA content of EV from routine blood draws and urine samples are likely to enable pathologists and physicians to diagnose and track the progress of diseases in many inaccessible tissues in the near future. Here we present the evolutionary background of EV, summarize the biology of EV formation and cargo selection, and discuss the current barriers to making continuous liquid biopsies through the use of EV a science reality.
Citations
Citations to this article as recorded by
Blood-derived APLP1
+
extracellular vesicles are potential biomarkers for the early diagnosis of brain diseases
Yuri Choi, Jae Hyun Park, Ala Jo, Chul-Woo Lim, Ji-Min Park, Jin Woo Hwang, Kang Soo Lee, Young-Sang Kim, Hakho Lee, Jisook Moon Science Advances.2025;[Epub] CrossRef
The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury Saranya Selvaraj, Laksiri Weerasinghe Central Nervous System Agents in Medicinal Chemistry.2025; 25(1): 20. CrossRef
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee Biomolecules.2024; 14(3): 277. CrossRef
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach Sonal Sukreet, Michael S. Rafii, Robert A. Rissman Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.2024;[Epub] CrossRef
Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression Akram Tayanloo-Beik, Azin Eslami, Masoumeh Sarvari, Hasan Jalaeikhoo, Mohsen Rajaeinejad, Mohsen Nikandish, Ali Faridfar, Mostafa Rezaei-Tavirani, Ahmad Rezazadeh Mafi, Bagher Larijani, Babak Arjmand Oncology Reviews.2024;[Epub] CrossRef
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers Prerna Dabral, Nobel Bhasin, Manish Ranjan, Maysoon M. Makhlouf, Zakaria Y. Abd Elmageed Cancers.2024; 16(13): 2462. CrossRef
miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma Jenni Karttunen, Lajos Kalmar, Andrew Grant, Jun Ying, Sarah E. Stewart, Xiaonan Wang, Fiona Karet Frankl, Tim Williams Scientific Reports.2024;[Epub] CrossRef
Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers Itze C. Navarro-Hernandez, Raúl F. Reyes-Huerta, Mariana Cañez-Hernández, Jiram Torres-Ruiz, Daniel A. Carrillo-Vázquez, Laura P. Whittall-García, David E. Meza-Sánchez, Guillermo Juárez-Vega, Diana Gómez-Martin, José M. Hernández-Hernández, José L. Marav Diagnostics.2024; 14(20): 2271. CrossRef
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations Luke Mansfield, Valentina Ramponi, Kavya Gupta, Thomas Stevenson, Abraham Binoy Mathew, Agian Jeffilano Barinda, Florencia Herbstein, Samir Morsli npj Aging.2024;[Epub] CrossRef
Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review Kaja Troha, Domen Vozel, Matevž Arko, Apolonija Bedina Zavec, Drago Dolinar, Matej Hočevar, Zala Jan, Matic Kisovec, Boštjan Kocjančič, Ljubiša Pađen, Manca Pajnič, Samo Penič, Anna Romolo, Neža Repar, Vesna Spasovski, Nejc Steiner, Vid Šuštar, Aleš Iglič International Journal of Molecular Sciences.2023; 24(4): 3420. CrossRef
Liquid Biopsies, Novel Approaches and Future Directions Athanasios Armakolas, Maria Kotsari, John Koskinas Cancers.2023; 15(5): 1579. CrossRef
Proteomic Signature of Extracellular Vesicles Associated with Colorectal Cancer Natalia Soloveva, Svetlana Novikova, Tatiana Farafonova, Olga Tikhonova, Victor Zgoda Molecules.2023; 28(10): 4227. CrossRef
Engineering extracellular vesicles for Alzheimer's disease: An emerging cell‐free approach for earlier diagnosis and treatment Sabrina Valentina Lazar, Sirjan Mor, David Wang, Leora Goldbloom‐Helzner, Kaitlin Clark, Dake Hao, Diana Lee Farmer, Aijun Wang WIREs Mechanisms of Disease.2022;[Epub] CrossRef
Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs Tao Feng, Johannes Karges, Xinxing Liao, Liangnian Ji, Hui Chao Coordination Chemistry Reviews.2022; 454: 214325. CrossRef
Storage conditions determine the characteristics of red blood cell derived extracellular vesicles Tímea Bebesi, Diána Kitka, Anikó Gaál, Imola Csilla Szigyártó, Róbert Deák, Tamás Beke-Somfai, Kitti Koprivanacz, Tünde Juhász, Attila Bóta, Zoltán Varga, Judith Mihály Scientific Reports.2022;[Epub] CrossRef
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis Tânia Soares Martins, Rui Marçalo, Cristóvão B. da Cruz e Silva, Dário Trindade, José Catita, Francisco Amado, Tânia Melo, Ilka Martins Rosa, Jonathan Vogelgsang, Jens Wiltfang, Odete A. B. da Cruz e Silva, Ana Gabriela Henriques Molecular Neurobiology.2022; 59(5): 2838. CrossRef
Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic? Aditi Patel, Shanaya Patel, Parina Patel, Vivek Tanavde Frontiers in Oncology.2022;[Epub] CrossRef
Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening Britton D. Rink, Blair K. Stevens, Mary E. Norton Obstetrics & Gynecology.2022;[Epub] CrossRef
Investigating the consistency of extracellular vesicle production from breast cancer subtypes using CELLine adherent bioreactors Colin L. Hisey, Anastasiia Artuyants, George Guo, Vanessa Chang, Gabrielle Reshef, Martin Middleditch, Bincy Jacob, Lawrence W. Chamley, Cherie Blenkiron Journal of Extracellular Biology.2022;[Epub] CrossRef
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease Tânia Soares Martins, Dário Trindade, Margarida Vaz, Inês Campelo, Martim Almeida, Guilherme Trigo, Odete A. B. da Cruz e Silva, Ana Gabriela Henriques Journal of Neurochemistry.2021; 156(2): 162. CrossRef
Composition of the whole transcriptome in the human plasma: Cellular source and modification by aging Tapio Nevalainen, Arttu Autio, Maija Puhka, Marja Jylhä, Mikko Hurme Experimental Gerontology.2021; 143: 111119. CrossRef
Extracellular vesicles in cancer diagnostics and therapeutics Adeeb Shehzad, Salman Ul Islam, Raheem Shahzad, Salman Khan, Young Sup Lee Pharmacology & Therapeutics.2021; 223: 107806. CrossRef
Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans Fanny M. Elahi, Danielle Harvey, Marie Altendahl, Nivetha Brathaban, Nicole Fernandes, Kaitlin B. Casaletto, Adam M. Staffaroni, Pauline Maillard, Jason D. Hinman, Bruce L. Miller, Charles DeCarli, Joel H. Kramer, Edward J. Goetzl Scientific Reports.2021;[Epub] CrossRef
Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications Renato Burgos-Ravanal, América Campos, Magda C. Díaz-Vesga, María Fernanda González, Daniela León, Lorena Lobos-González, Lisette Leyton, Marcelo J. Kogan, Andrew F. G. Quest Cancers.2021; 13(13): 3324. CrossRef
Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical Applications Maria Chiara Ciferri, Rodolfo Quarto, Roberta Tasso Biology.2021; 10(5): 359. CrossRef
A multiparametric extraction method for Vn96-isolated plasma extracellular vesicles and cell-free DNA that enables multi-omic profiling Jeremy W. Roy, Catherine A. Taylor, Annie P. Beauregard, Surendar R. Dhadi, D. Craig Ayre, Sheena Fry, Simi Chacko, Gabriel Wajnberg, Andrew P. Joy, Ngoc-Nu Mai-Thi, Nicolas Crapoulet, David A. Barnett, Anirban Ghosh, Stephen M. Lewis, Rodney J. Ouellette Scientific Reports.2021;[Epub] CrossRef
The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironment Hanyu Zhang, Min Yang, Xu Wu, Qianxiu Li, Xin Li, Yueshui Zhao, Fukuan Du, Yu Chen, Zhigui Wu, Zhangang Xiao, Jing Shen, Qinglian Wen, Wei Hu, Chi Hin Cho, Meijuan Chen, Yejiang Zhou, Mingxing Li Pharmacological Research.2021; 171: 105785. CrossRef
Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics Hagar M. Soliman, Ghada A. Ghonaim, Shaza M. Gharib, Hitesh Chopra, Aya K. Farag, Mohamed H. Hassanin, Abdalrazeq Nagah, Mahmoud Emad-Eldin, Nevertary E. Hashem, Galal Yahya, Sherif E. Emam, Abdalla E. A. Hassan, Mohamed S. Attia International Journal of Molecular Sciences.2021; 22(19): 10794. CrossRef
Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury Wylly Ramsés García-Niño, Cecilia Zazueta, Mabel Buelna-Chontal, Alejandro Silva-Palacios Life.2021; 11(11): 1123. CrossRef
Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers Sunitha Kodidela, Yujie Wang, Benjamin J. Patters, Yuqing Gong, Namita Sinha, Sabina Ranjit, Kelli Gerth, Sanjana Haque, Theodore Cory, Carole McArthur, Anil Kumar, Jim Y. Wan, Santosh Kumar Journal of Neuroimmune Pharmacology.2020; 15(3): 501. CrossRef
Promising Applications of AIEgens in Animal Models Bairong He, Bo Situ, Zujin Zhao, Lei Zheng Small Methods.2020;[Epub] CrossRef
Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes Tine Tesovnik, Jernej Kovač, Katka Pohar, Samo Hudoklin, Klemen Dovč, Nataša Bratina, Katarina Trebušak Podkrajšek, Maruša Debeljak, Peter Veranič, Emanuele Bosi, Lorenzo Piemonti, Alojz Ihan, Tadej Battelino Frontiers in Cell and Developmental Biology.2020;[Epub] CrossRef
The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance Cristina P. R. Xavier, Hugo R. Caires, Mélanie A. G. Barbosa, Rui Bergantim, José E. Guimarães, M. Helena Vasconcelos Cells.2020; 9(5): 1141. CrossRef
Connexin-46 Contained in Extracellular Vesicles Enhance Malignancy Features in Breast Cancer Cells Rodrigo A. Acuña, Manuel Varas-Godoy, Viviana M. Berthoud, Ivan E. Alfaro, Mauricio A. Retamal Biomolecules.2020; 10(5): 676. CrossRef
Mentalexo approach for diagnosis of psychiatric disorders Ahmet Topuzoğlu, Can Ilgın Medical Hypotheses.2020; 143: 109823. CrossRef
Reagent-free total protein quantification of intact extracellular vesicles by attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy Veronika Szentirmai, András Wacha, Csaba Németh, Diána Kitka, Anita Rácz, Károly Héberger, Judith Mihály, Zoltán Varga Analytical and Bioanalytical Chemistry.2020; 412(19): 4619. CrossRef
Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles Manuel Castanheira de Oliveira, Hugo R. Caires, Maria J. Oliveira, Avelino Fraga, M. Helena Vasconcelos, Ricardo Ribeiro Cancers.2020; 12(6): 1400. CrossRef
(Sub)populations of extracellular vesicles released by TNF‐α –triggered human endothelial cells promote vascular inflammation and monocyte migration Baharak Hosseinkhani, Nynke M.S. van den Akker, Daniel G.M. Molin, Luc Michiels Journal of Extracellular Vesicles.2020;[Epub] CrossRef
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma In Ae Kim, Jae Young Hur, Hee Joung Kim, Seung Eun Lee, Wan Seop Kim, Kye Young Lee Journal of Pathology and Translational Medicine.2020; 54(6): 453. CrossRef
Mitochondrial RNA in Alzheimer’s Disease Circulating Extracellular Vesicles Kyoung Mi Kim, Qiong Meng, Olivia Perez de Acha, Maja Mustapic, Aiwu Cheng, Erden Eren, Gautam Kundu, Yulan Piao, Rachel Munk, William H. Wood, Supriyo De, Ji Heon Noh, Michael Delannoy, Lesley Cheng, Kotb Abdelmohsen, Dimitrios Kapogiannis, Myriam Gorosp Frontiers in Cell and Developmental Biology.2020;[Epub] CrossRef
Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles Asit Kumar, Lina Zhou, Kaining Zhi, Babatunde Raji, Shelby Pernell, Erene Tadrous, Sunitha Kodidela, Anantha Nookala, Harry Kochat, Santosh Kumar International Journal of Molecular Sciences.2020; 22(1): 138. CrossRef
Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients Kristina Magaard Koldby, Michael Bau Mortensen, Sönke Detlefsen, Per Pfeiffer, Mads Thomassen, Torben A. Kruse Journal of Gastroenterology.2019; 54(2): 108. CrossRef
Raman tweezers microspectroscopy of circa 100 nm extracellular vesicles Sergei G. Kruglik, Félix Royo, Jean-Michel Guigner, Laura Palomo, Olivier Seksek, Pierre-Yves Turpin, Irène Tatischeff, Juan M. Falcón-Pérez Nanoscale.2019; 11(4): 1661. CrossRef
Application of Extracellular Vesicles Proteomics to Cardiovascular Disease: Guidelines, Data Analysis, and Future Perspectives Maria N. Barrachina, Beatriz Calderón‐Cruz, Lucía Fernandez‐Rocca, Ángel García PROTEOMICS.2019;[Epub] CrossRef
Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung Hyun Min Koh, Hyo Jung An, Gyung Hyuck Ko, Jeong Hee Lee, Jong Sil Lee, Dong Chul Kim, Jung Wook Yang, Min Hye Kim, Sung Hwan Kim, Kyung Nyeo Jeon, Gyeong-Won Lee, Se Min Jang, Dae Hyun Song Journal of Pathology and Translational Medicine.2019; 53(1): 13. CrossRef
High-fidelity probing of the structure and heterogeneity of extracellular vesicles by resonance-enhanced atomic force microscopy infrared spectroscopy Sally Yunsun Kim, Dipesh Khanal, Bill Kalionis, Wojciech Chrzanowski Nature Protocols.2019; 14(2): 576. CrossRef
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy Trends in Pharmacological Sciences.2019; 40(3): 172. CrossRef
Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and Treatments Ritu Jaiswal, Lisa M. Sedger Frontiers in Oncology.2019;[Epub] CrossRef
Dictyostelium: A Model for Studying the Extracellular Vesicle Messengers Involved in Human Health and Disease Irène Tatischeff Cells.2019; 8(3): 225. CrossRef
Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies Jenni Karttunen, Mette Heiskanen, Anssi Lipponen, David Poulsen, Asla Pitkänen International Journal of Molecular Sciences.2019; 20(6): 1259. CrossRef
Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs Hiroshi Ageta, Kunihiro Tsuchida Cellular and Molecular Life Sciences.2019; 76(24): 4829. CrossRef
Exosome release and cargo in Down syndrome Eric D. Hamlett, Angela LaRosa, Elliott J. Mufson, Juan Fortea, Aurélie Ledreux, Ann‐Charlotte Granholm Developmental Neurobiology.2019; 79(7): 639. CrossRef
Exosomes in specific fractions of the boar ejaculate contain CD44: A marker for epididymosomes? Manuel Alvarez-Rodriguez, Stefan A. Ljunggren, Helen Karlsson, Heriberto Rodriguez-Martinez Theriogenology.2019; 140: 143. CrossRef
A review on protein markers of exosome from different bio-resources and the antibodies used for characterization Fengyan Deng, Josh Miller Journal of Histotechnology.2019; 42(4): 226. CrossRef
Tangential Flow Microfluidics for the Capture and Release of Nanoparticles and Extracellular Vesicles on Conventional and Ultrathin Membranes Mehdi Dehghani, Kilean Lucas, Jonathan Flax, James McGrath, Thomas Gaborski Advanced Materials Technologies.2019;[Epub] CrossRef
Lipidomic analysis of urinary exosomes from hereditary α‐tryptasemia patients and healthy volunteers Sarah C. Glover, Mohammad‐Zaman Nouri, Kubra M. Tuna, Lybil B. Mendoza Alvarez, Lisa K. Ryan, James F. Shirley, Ying Tang, Nancy D. Denslow, Abdel A. Alli FASEB BioAdvances.2019; 1(10): 624. CrossRef
Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers Valentina Karin-Kujundzic, Ida Marija Sola, Nina Predavec, Anamarija Potkonjak, Ema Somen, Pavao Mioc, Alan Serman, Semir Vranic, Ljiljana Serman Cells.2019; 8(11): 1459. CrossRef
The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer Emne A. Abdallah, Alexcia C. Braun, Bianca C.T.C.P. Flores, Laís Senda, Ana Cláudia Urvanegia, Vinicius Calsavara, Victor Hugo Fonseca de Jesus, Maria Fernanda Arruda Almeida, Maria Dirlei Begnami, Felipe J.F. Coimbra, Wilson Luiz da Costa, Diana Noronha The Oncologist.2019; 24(9): e854. CrossRef
Role of tumor‑derived extracellular vesicles in cancer progression and their clinical applications (Review) Fuhao Qiao, Peng Pan, Jiaping Yan, Jing Sun, Yan Zong, Zhiyong Wu, Xiaoqin Lu, Na Chen, Rui Mi, Yongbin Ma, Yuan Ji International Journal of Oncology.2019;[Epub] CrossRef
Circulating tumor DNA – Current state of play and future perspectives Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy Pharmacological Research.2018; 136: 35. CrossRef
“Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders Fanny M. Elahi, Kaitlin B. Casaletto, Marie Altendahl, Adam M. Staffaroni, Evan Fletcher, Teresa J. Filshtein, Maria M. Glymour, Bruce L. Miller, Jason D. Hinman, Charles DeCarli, Edward J. Goetzl, Joel H. Kramer Frontiers in Aging Neuroscience.2018;[Epub] CrossRef
The role of exosomal transport of viral agents in persistent HIV pathogenesis Benjamin J. Patters, Santosh Kumar Retrovirology.2018;[Epub] CrossRef
Background The immunotherapeutic role of programmed death-ligand 1 (PD-L1) in life expectancy in many cancers has been highlighted. However, data regarding PD-L1 expression in papillary thyroid carcinoma (PTC) are limited. In this study, we describe the PD-L1 and programmed cell death protein 1 (PD-1) expressions in PTC and analyze their correlation with lymph node (LN) metastasis.
Methods Clinicopathological data were obtained from 116 patients with PTC who were treated in Gyeongsang National University Hospital, Jinju, Korea in 2009. Tissue microarray blocks were made using representative paraffin blocks of classical PTCs excluding follicular variants. Two pathologists graded the proportion and intensity of PD-L1 and PD-1 expression in both tumor and inflammatory cells. According to their proportions, positive PTC cells were scored as negative (0%), grade 1 (1%–50%), and grade 2 (51%–100%). Similarly, positive inflammatory cells were graded as negative (0%), grade 1 (1%–10%), and grade 2 (11%–20%). The intensity of each protein expression was simplified as positive or negative.
Results A statistically significant correlation exists between the proportions of PD-1 and PD-L1 expression both in papillary carcinoma (p=.001) and peritumoral lymphoid cells in the thyroid (p<.001). In addition, the proportion of PD-L1 expression in PTC cells was closely related to metastatic LNs (p=.036).
Conclusions PD-L1 is a valuable predictive marker for LN metastasis in PTC. Immunomodulating therapies that inhibit PD-L1 might be an option for patients with LN metastasis.
Citations
Citations to this article as recorded by
Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma Vitor Barreto Santana, Vitória Machado Krüger, Maria Cristina Yunes Abrahão, Pietru Lentz Martins Cantú, Rosicler Luzia Brackmann, Gisele Moroni Pandolfi, Liane Scheffler Marisco, Gabriela Remonatto, Luciana Adolfo Ferreira, Marcia Silveira Graudenz Head and Neck Pathology.2024;[Epub] CrossRef
Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies Atish Mohanty, Michelle Afkhami, Amanda Reyes, Rebecca Pharaon, Holly Yin, Haiqing Li, Dana Do, Diana Bell, Arin Nam, Sue Chang, Thomas Gernon, Robert Kang, Arya Amini, Sagus Sampath, Prakash Kulkarni, Raju Pillai, Vicky Villaflor, Ravi Salgia, Ellie Magh Journal for ImmunoTherapy of Cancer.2024; 12(7): e008505. CrossRef
Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples Marco Dell'Aquila, Pietro Tralongo, Alessia Granitto, Maurizio Martini, Sara Capodimonti, Mariangela Curatolo, Vincenzo Fiorentino, Alfredo Pontecorvi, Guido Fadda, Celestino Pio Lombardi, Maco Raffaelli, Liron Pantanowitz, Luigi Maria Larocca, Esther Dia Journal of Clinical Pathology.2023; 76(10): 671. CrossRef
Analysis of anti‐apoptotic PVT1 oncogene and apoptosis‐related proteins (p53, Bcl2, PD‐1, and PD‐L1) expression in thyroid carcinoma Afaf T. Ibrahiem, Amin K. Makhdoom, Khalid S. Alanazi, Abdulaziz M. Alanazi, Abdulaziz M. Mukhlef, Saad H. Elshafey, Eman A. Toraih, Manal S. Fawzy Journal of Clinical Laboratory Analysis.2022;[Epub] CrossRef
EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma Wenyue Zhao, Lu Liu, Xuehao Li, Shun Xu International Immunopharmacology.2022; 110: 109031. CrossRef
Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas Peter P. Issa, Mahmoud Omar, Yusef Buti, Chad P. Issa, Bert Chabot, Christopher J. Carnabatu, Ruhul Munshi, Mohammad Hussein, Mohamed Aboueisha, Mohamed Shama, Ralph L. Corsetti, Eman Toraih, Emad Kandil Biomedicines.2022; 10(8): 2051. CrossRef
Expression of β-Catenin in Thyroid Neoplasms (Histopathological and Immunohistochemical Study) Mohamed Sherif Ismail, Amr Mousa Abdel Gawad Mousa, Mohammed Faisal Darwish, M. Mostafa Salem, Randa Said Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 1565. CrossRef
Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma Rujia Qin, Chunyan Li, Xuemin Wang, Zhaoming Zhong, Chuanzheng Sun Cancer Cell International.2021;[Epub] CrossRef
PD‐L1 and thyroid cytology: A possible diagnostic and prognostic marker Marco Dell’Aquila, Alessia Granitto, Maurizio Martini, Sara Capodimonti, Alessandra Cocomazzi, Teresa Musarra, Vincenzo Fiorentino, Alfredo Pontecorvi, Celestino Pio Lombardi, Guido Fadda, Liron Pantanowitz, Luigi Maria Larocca, Esther Diana Rossi Cancer Cytopathology.2020; 128(3): 177. CrossRef
Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma Ilaria Girolami, Liron Pantanowitz, Ozgur Mete, Matteo Brunelli, Stefano Marletta, Chiara Colato, Pierpaolo Trimboli, Anna Crescenzi, Massimo Bongiovanni, Mattia Barbareschi, Albino Eccher Endocrine Pathology.2020; 31(3): 291. CrossRef
Regression of Papillary Thyroid Cancer during Nivolumab for Renal Cell Cancer Andrea Palermo, Andrea Napolitano, Daria Maggi, Anda Mihaela Naciu, Gaia Tabacco, Silvia Manfrini, Anna Crescenzi, Chiara Taffon, Francesco Pantano, Bruno Vincenzi, Guiseppe Tonini, Daniele Santini European Thyroid Journal.2020; 9(3): 157. CrossRef
A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma Xian Wang, Shan Huang, Xiaocan Li, Dongrui Jiang, Hongzhen Yu, Qiang Wu, Chaobing Gao, Zhengsheng Wu, Yi-Hsien Hsieh PLOS ONE.2018; 13(7): e0200290. CrossRef
Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis Daniel Lubin, Ezra Baraban, Amanda Lisby, Sahar Jalali-Farahani, Paul Zhang, Virginia Livolsi Endocrine Pathology.2018; 29(4): 317. CrossRef
Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation Hoi Yan Ng, Jian Li, Lihua Tao, Alfred King-Yin Lam, Kwok Wah Chan, Josephine Mun Yee Ko, Valen Zhuoyou Yu, Michael Wong, Benjamin Li, Maria Li Lung Translational Oncology.2018; 11(6): 1323. CrossRef
Background Trophoblast antigen 2 (TROP2) is a human trophoblast cell-surface glycoprotein that is overexpressed in several types of epithelial cancers, and is suggested to be associated with an unfavorable prognosis. BRAF mutations are the most common genetic alteration in papillary thyroid carcinoma (PTC). We evaluated the correlation between TROP2 expression and BRAF mutation in PTC.
Methods First, we carried out pyrosequencing for BRAF mutations and immunohistochemistry for TROP2 expression with a tissue microarray consisting of 52 PTC cases. Membranous staining in at least 5% of tumor cells was designated as positive staining and we analyzed the relationship between TROP2 expression and diverse clinicopathological factors, including BRAF mutation. Second, we tested TROP2 mRNA expression in three thyroid cancer cell lines with BRAF mutations (BCPAP, SNU790, and 8505C) and a normal thyroid cell line. Additionally, we checked TROP2 protein levels in a normal thyroid cell line after introduction of the BRAF V600E mutation.
Results In this study, 21 of 26 cases with BRAF mutation showed TROP2 immunoreactivity, whereas all 26 cases without BRAF mutation showed no immunoreactivity for TROP2 with a statistically significant difference (p<.001). Upregulation of TROP2 mRNA was observed in all three thyroid cancer cell lines, but not in the normal thyroid cell line. Interestingly, however, the TROP2 expression was increased in the normal thyroid cell line after introduction of the BRAF V600E mutation.
Conclusions Based on these results, we concluded that TROP2 expression is significantly associated with BRAF mutation and that TROP2 immunohistochemistry could be used for predicting BRAF mutations or diagnosing papillary thyroid carcinoma.
Citations
Citations to this article as recorded by
Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma Amany Selim Attia, Samia Hussein, Hend Sameh, Amr Khalil, Ahmad Barakat Waley, Ihab Matar, Reham Sameh Cancer Biomarkers.2024; 39(3): 211. CrossRef
BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases David Kalfert, Marie Ludvikova, Martin Pesta, Tommi Hakala, Lucie Dostalova, Hana Grundmannova, Jindra Windrichova, Katerina Houfkova, Tereza Knizkova, Jaroslav Ludvik, Jiri Polivka, Ivana Kholova Pathology - Research and Practice.2024; 258: 155319. CrossRef
Unveiling the placental secrets: Exploring histopathological changes and TROP2 expression in intrahepatic cholestasis of pregnancy Cezmi Baran Ozalp, Sozdar Akdogan, Dilan Cetinavci, Melike Nur Akin, Hulya Elbe, Burcu Kasap Placenta.2024; 154: 201. CrossRef
Trop2-Targeted Molecular Imaging in Solid Tumors: Current Advances and Future Outlook Yongshun Liu, Wenpeng Huang, Rachel J. Saladin, Jessica C. Hsu, Weibo Cai, Lei Kang Molecular Pharmaceutics.2024; 21(12): 5909. CrossRef
TROP2 is a Good Indicator for Infiltrative Nature of Carcinoma Rather than Diagnosing Malignancy in Thyroid E. Kılınc, P. Gunes, A. Doganer Indian Journal of Otolaryngology and Head & Neck Surgery.2022; 74(S2): 2560. CrossRef
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer Xinlin Liu, Junwen Deng, Yang Yuan, Wujun Chen, Wenshe Sun, Yanhong Wang, Haiming Huang, Bing Liang, Tao Ming, Jialian Wen, Binghuan Huang, Dongming Xing Pharmacology & Therapeutics.2022; 239: 108296. CrossRef
Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β‐catenin pathway Xiaotong Sun, Guangyang Xing, Cui Zhang, Kun Lu, Yuqiong Wang, Xiyan He Cell Biochemistry and Function.2020; 38(2): 141. CrossRef
Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma? SerkanY Celik, Özgürİlhan Çelik Indian Journal of Pathology and Microbiology.2020; 63(3): 418. CrossRef
Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens Asmaa Gaber Abdou, Mohammed Shabaan, Rania Abdallha, Nehal Nabil Clinical Pathology.2019;[Epub] CrossRef
Evaluation of Diagnostic Utility of Immunohistochemistry Markers of TROP-2 and HBME-1 in the Diagnosis of Thyroid Carcinoma Nooshin Zargari, Maral Mokhtari European Thyroid Journal.2019; 8(1): 1. CrossRef
The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma Xueyang Yang, Yifang Hu, He Shi, Chengzhou Zhang, Zhixiao Wang, Xiaoyun Liu, Huanhuan Chen, Lijuan Zhang, Dai Cui European Archives of Oto-Rhino-Laryngology.2018; 275(8): 2127. CrossRef
TROP2 promotes cell proliferation and migration in osteosarcoma through PI3K/AKT signaling Qing‑Zhi Gu, Abulimiti Nijiati, Xing Gao, Kai‑Liang Tao, Cheng‑Duo Li, Xue‑Peng Fan, Zheng Tian Molecular Medicine Reports.2018;[Epub] CrossRef
Background The objective of this study was to compare the classical method and Sectioning and Extensively Examining the Fimbriated End Protocol (SEE-FIM) in detecting microscopic lesions in fallopian tubes with gynecological lesions. Methods: From a total of 1,118 cases, 582 with various parts of both fallopian tubes sampled in three-ring-shape sections and 536 sampled with the SEE-FIM protocol were included in this study. Pathological findings of cases with endometrial carcinoma, non-uterine pelvic malignant tumor, ovarian borderline tumors, premalignancy, and benign lesions were compared. Results: We detected two tubal infiltrative carcinomas among 40 uterine endometrioid adenocarcinomas, 15 serous tubal intraepithelial carcinomas in 39 non-uterine pelvic serous high-grade carcinoma cases, seven papillary tubal hyperplasias in 13 serous borderline tumor cases, and 11 endometriotic foci and four adenomatoid tumors among all cases sampled with the SEE-FIM protocol. Using the classical method, we detected only one serous tubal intraepithelial carcinoma in 113 non-uterine pelvic serous high-grade carcinoma cases and two papillary tubal hyperplasia cases in 31 serous borderline tumors. We did not identify additional findings in 185 uterine endometrioid carcinoma cases, and neither endometriotic focus nor adenomatoid tumor was shown in other lesions by the classical method. Conclusions: Benign, premalignant, and malignant lesions can possibly be missed using the classical method. The SEE-FIM protocol should be considered especially in cases of endometrial carcinoma, nonuterine pelvic serous cancers, or serous borderline ovarian tumors. For other lesions, at least a detailed examination of the fimbrial end should be undertaken.
Citations
Citations to this article as recorded by
Volumetric sonographic depiction of the fallopian tube lumen for the early detection of tubal abnormalities: A work in progress Jessica P. Miller, Ryan G. Morrison, Emily Mechling, Karen Tisdale, Katherine Frederick-Dyer, Brannan B. Griffin, Ben H. Park, Lauren S. Prescott, Marta A. Crispens, Ronald Alvarez, Arthur Fleischer WFUMB Ultrasound Open.2024; 2(1): 100031. CrossRef
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease J.A. Ledermann, X. Matias-Guiu, F. Amant, N. Concin, B. Davidson, C. Fotopoulou, A. González-Martin, C. Gourley, A. Leary, D. Lorusso, S. Banerjee, L. Chiva, D. Cibula, N. Colombo, S. Croce, A.G. Eriksson, C. Falandry, D. Fischerova, P. Harter, F. Joly, C Annals of Oncology.2024; 35(3): 248. CrossRef
Incidental Serous Tubal Intraepithelial Carcinoma Finding in a Nepalese Patient Undergoing Opportunistic Salpingectomy and the Discovery of a BRCA1 Pathogenic Variant Kristin M. Tischer, Siddhartha Yadav, Debra Bell, Kathleen Hansen, Larissa N. Veres, Brandon Maddy, Jamie N. Bakkum-Gamez O&G Open.2024; : 009. CrossRef
Prevention of Ovarian Cancer: Where are We Now and Where are We Going? Isabel V. Rodriguez, Talayeh Ghezelayagh, Kathryn P. Pennington, Barbara M. Norquist Current Oncology Reports.2024; 26(11): 1355. CrossRef
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study Eric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, El Houssein, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet, Yves Fouche, Sébastien Gouy, Pierre Collinet, Frédéric Caquant, Christophe Pomel, Franç Cancers.2023; 15(4): 1141. CrossRef
Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study Joep M A Bogaerts, Majke H D van Bommel, Rosella P M G Hermens, Miranda P Steenbeek, Joanne A de Hullu, Jeroen A W M van der Laak, Michiel Simons Histopathology.2023; 83(1): 67. CrossRef
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis Xia Wei, Samuel Oxley, Michail Sideris, Ashwin Kalra, Adam Brentnall, Li Sun, Li Yang, Rosa Legood, Ranjit Manchanda American Journal of Obstetrics and Gynecology.2023; 229(4): 388. CrossRef
Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists Pegah Blustein, Sarah R. Werner, Pooja Uppalapati, Tung Ming Leung, Gregg A. Husk, Elena B. Pereira, Jill S. Whyte, Jeannine A. Villella American Journal of Obstetrics and Gynecology.2023; 229(3): 280.e1. CrossRef
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study Ashley S. Felix, Jennifer A. Sinnott, David E. Cohn, Máire A. Duggan, Laura J. Havrilesky, Alexander B. Olawaiye, Andrea Mariani, Monica Rodriquez, Mary Anne Brett, Giorgia Dinoi, Caitlin E. Meade, Bobbie Hall, Ester Goldfeld, Esther Elishaev, Mark E. She Gynecologic Oncology.2023; 178: 130. CrossRef
Recommendations for diagnosing STIC: a systematic review and meta-analysis Joep M. A. Bogaerts, Miranda P. Steenbeek, Majke H. D. van Bommel, Johan Bulten, Jeroen A. W. M. van der Laak, Joanne A. de Hullu, Michiel Simons Virchows Archiv.2022; 480(4): 725. CrossRef
Magnetic resonance imaging findings of extrauterine high-grade serous carcinoma based on new pathologic criteria for primary site assignment Masaya Kawaguchi, Hiroki Kato, Yuichiro Hatano, Hiroyuki Tomita, Akira Hara, Tatsuhiko Miyazaki, Masayuki Matsuo Acta Radiologica.2021; 62(5): 687. CrossRef
Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO) Therese Pross, Maria Margarete Karsten, Jens-Uwe Blohmer, Dorothee Speiser Geburtshilfe und Frauenheilkunde.2021; 81(09): 1031. CrossRef
Histomorphological Spectrum of Incidentally Detected Fallopian Tube Lesions in Patients Operated for Various Clinical Conditions and Detection of Precursor Lesion by Applying Sectioning and Extensively Examining the Fimbriated End Sampling Protocol Neha Singh, Ipsita Dhal, Aneesha Mohanpuria, Swati Saxena Oncology Journal of India.2021; 5(3): 85. CrossRef
Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices Laura K. Newcomb, Coralee T. Toal, Noah B. Rindos, Li Wang, Suketu M. Mansuria Journal of Minimally Invasive Gynecology.2020; 27(7): 1511. CrossRef
Serous Tubal Intraepithelial Carcinoma: A Concise Review for the Practicing Pathologist and Clinician S. Emily Bachert, Anthony McDowell, Dava Piecoro, Lauren Baldwin Branch Diagnostics.2020; 10(2): 102. CrossRef
An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions Marie E. Perrone, Nicholas P. Reder, Sergay N. Agoff, Rochelle L. Garcia, Kathy J. Agnew, Barbara M. Norquist, Kathryn P. Pennington, Elizabeth M. Swisher, Mark R. Kilgore International Journal of Gynecological Pathology.2020; 39(3): 261. CrossRef
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years Arielle S. Weiss, Elizabeth Swisher, Kathryn P. Pennington, Marc Radke, Nithisha Khasnavis, Rochelle L. Garcia, Mark R. Kilgore, Ming K. Lee, Barbara M. Norquist Gynecologic Oncology.2020; 159(1): 214. CrossRef
Grossing Issues in Ovarian and Fallopian Tube Pathology Lakshmi Shree Kulumani Mahadevan, Byoung Uk Park, I-Tien Yeh AJSP: Reviews and Reports.2020; 25(4): 174. CrossRef
Ovarian Serous Carcinoma: A Retrospective Study of Clinicopathological Findings and Postchemotherapy Changes Navatha Vangala, Shantveer G Uppin, Megha S Uppin, Tara Roshni Paul, G Sadashivudu Indian Journal of Medical and Paediatric Oncology.2020; 41(05): 663. CrossRef
Sectioning and extensively examining the fimbriated end (SEE‐FIM) of the fallopian tube in routine practices, is it worth the effort? Natthawadee Laokulrath, Malee Warnnissorn, Tuenjai Chuangsuwanich, Suchanan Hanamornroongruang Journal of Obstetrics and Gynaecology Research.2019; 45(3): 665. CrossRef
Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists Anais Malpica, Elizabeth D. Euscher, Jonathan L. Hecht, Rouba Ali-Fehmi, Charles M. Quick, Naveena Singh, Lars-Christian Horn, Isabel Alvarado-Cabrero, Xavier Matias-Guiu, Lynn Hirschowitz, Máire Duggan, Jaume Ordi, Vinita Parkash, Yoshiki Mikami, M. Ruhu International Journal of Gynecological Pathology.2019; 38(Supplement): S9. CrossRef
Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer Alexandra S. Bercow, Eric L. Eisenhauer Journal of Surgical Oncology.2019; 120(5): 864. CrossRef
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo Cochrane Database of Systematic Reviews.2018;[Epub] CrossRef
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo Cochrane Database of Systematic Reviews.2016;[Epub] CrossRef
Background Mixed gliomas, such as oligoastrocytomas (OA), anaplastic oligoastrocytomas, and glioblastomas (GBMs) with an oligodendroglial component (GBMO) are defined as tumors composed of a mixture of two distinct neoplastic cell types, astrocytic and oligodendroglial. Recently, mutations ATRX and TP53, and codeletion of 1p/19q are shown to be genetic hallmarks of astrocytic and oligodendroglial tumors, respectively. Subsequent molecular analyses of mixed gliomas preferred the reclassification to either oligodendroglioma or astrocytoma. This study was designed to apply genetically integrated diagnostic criteria to mixed gliomas and determine usefulness and prognostic value of new classification in Korean patients.
Methods Fifty-eight cases of mixed OAs and GBMOs were retrieved from the pathology archives of Seoul National University Hospital from 2004 to 2015. Reclassification was performed according to genetic and immunohistochemical properties. Clinicopathological characteristics of each subgroup were evaluated. Overall survival was assessed and compared between subgroups.
Results We could reclassify all mixed OAs and GBMOs into either astrocytic or oligodendroglial tumors. Notably, 29 GBMOs could be reclassified into 11 cases of GBM, IDH-mutant, 16 cases of GBM, IDH-wildtype, and two cases of anaplastic oligodendroglioma, IDH mutant. Overall survival was significantly different among these new groups (p<.001). Overall survival and progression-free survival were statistically better in gliomas with IDH mutation, ATRX mutation, no microscopic necrosis, and young patient age (cut off, 45 years old).
Conclusions Our results strongly suggest that a genetically integrated diagnosis of glioma better reflects prognosis than former morphology-based methods.
Citations
Citations to this article as recorded by
SNUH methylation classifier for CNS tumors Kwanghoon Lee, Jaemin Jeon, Jin Woo Park, Suwan Yu, Jae-Kyung Won, Kwangsoo Kim, Chul-Kee Park, Sung-Hye Park Clinical Epigenetics.2025;[Epub] CrossRef
The prognostic significance of p16 expression pattern in diffuse gliomas Jin Woo Park, Jeongwan Kang, Ka Young Lim, Hyunhee Kim, Seong-Ik Kim, Jae Kyung Won, Chul-Kee Park, Sung-Hye Park Journal of Pathology and Translational Medicine.2021; 55(2): 102. CrossRef
Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach Anna Latysheva, Kyrre Eeg Emblem, Petter Brandal, Einar Osland Vik-Mo, Jens Pahnke, Kjetil Røysland, John K. Hald, Andrés Server Neuroradiology.2019; 61(5): 545. CrossRef
Background Smad4 and PTEN are prognostic indicators for various tumor types. Smad4 regulates tumor suppression, whereas PTEN inhibits cell proliferation. We analyzed and compared the performance of Smad4 and PTEN for predicting the prognosis of patients with colorectal adenocarcinoma.
Methods Combined expression patterns based on Smad4+/– and PTEN+/– status were evaluated by immunostaining using a tissue microarray of colorectal adenocarcinoma. The relationships between the protein expression and clinicopathological variables were analyzed.
Results Smad4–/PTEN– status was most frequently observed in metastatic adenocarcinoma, followed by primary adenocarcinoma and tubular adenoma (p<.001). When Smad4–/PTEN– and Smad4+/PTEN+ groups were compared, Smad4–/PTEN– status was associated with high N stage (p=.018) and defective mismatch repair proteins (p=.006). Significant differences in diseasefree survival and overall survival were observed among the three groups (Smad4+/PTEN+, Smad4–/PTEN+ or Smad4+/PTEN–, and Smad4–/PTEN–) (all p<.05).
Conclusions Concurrent loss of Smad4 and PTEN may lead to more aggressive disease and poor prognosis in patients with colorectal adenocarcinoma compared to the loss of Smad4 or PTEN alone.
Citations
Citations to this article as recorded by
Association between the expression of epithelial–mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer Mona Hany Emile, Sameh Hany Emile, Amr Awad El-Karef, Mohamed Awad Ebrahim, Ibrahim Eldosoky Mohammed, Dina Abdallah Ibrahim Updates in Surgery.2024; 76(6): 2181. CrossRef
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study Michela Roberto, Giulia Arrivi, Emanuela Pilozzi, Andrea Montori, Genoveffa Balducci, Paolo Mercantini, Andrea Laghi, Debora Ierinò, Martina Panebianco, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Federica Mazzuca Cancer Management and Research.2022; Volume 14: 1353. CrossRef
Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay Menha Swellam, Entsar A. Saad, Shimaa Sabry, Adel Denewer, Camelia Abdel Malak, Amr Abouzid Journal of Genetic Engineering and Biotechnology.2021; 19(1): 54. CrossRef
E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4 Chen Lu, Guangyao Ning, Panpan Si, Chunsheng Zhang, Wenjian Liu, Wei Ge, Kai Cui, Renquan Zhang, Shenglin Ge Biochemistry and Cell Biology.2021; 99(5): 675. CrossRef
Computational quantification of global effects induced by mutations and drugs in signaling networks of colorectal cancer cells Sara Sommariva, Giacomo Caviglia, Silvia Ravera, Francesco Frassoni, Federico Benvenuto, Lorenzo Tortolina, Nicoletta Castagnino, Silvio Parodi, Michele Piana Scientific Reports.2021;[Epub] CrossRef
Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study Xiaoyan Liao, Yansheng Hao, Xiaofei Zhang, Stephen Ward, Jane Houldsworth, Alexandros D. Polydorides, Noam Harpaz, Aldo Scarpa PLOS ONE.2019; 14(2): e0212142. CrossRef
Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma Seung-Yeon Yoo, Ji-Ae Lee, Yunjoo Shin, Nam-Yun Cho, Jeong Mo Bae, Gyeong Hoon Kang Journal of Pathology and Translational Medicine.2019; 53(5): 289. CrossRef
Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer Ion Cristóbal, Blanca Torrejón, Andrea Santos, Melani Luque, Marta Sanz-Alvarez, Federico Rojo, Jesús García-Foncillas European Journal of Surgical Oncology.2018; 44(8): 1283. CrossRef
Reply to: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer Jordan M. Cloyd, Takashi Mizuno, Jean-Nicolas Vauthey European Journal of Surgical Oncology.2018; 44(8): 1285. CrossRef
Background Although histological diagnosis of pilomatricoma is not difficult because of its unique histological features, cytological diagnosis through fine-needle aspiration cytology (FNAC) is often problematic due to misdiagnoses as malignancy.
Methods We reviewed the cytological features of 14 cases of histologically-proven pilomatricoma from Korea Cancer Center Hospital, with a discussion on the diagnostic pitfalls of FNAC.
Results Among 14 cases of pilomatricoma, 10 (71.4%) were correctly diagnosed through FNAC, and two (14.3%) were misdiagnosed as carcinoma. Cytologically, all cases had easily recognizable clusters of basaloid cells and foreign body-type multinucleated cells. Although ghost cells were also found in all cases, some were inconspicuous and hardly recognizable due to their small numbers.
Conclusions An accurate diagnosis of pilomatricoma in FNAC is feasible with consideration of clinical information and close examination of ghost cells.
Citations
Citations to this article as recorded by
A case of pilomatricoma with suspected malignancy diagnosed by intraoperative rapid cytological diagnosis Miho YOSHIDA-TANAKA, Kazuya KURAOKA, Naoko YASUMURA, Arisa KAN, Yumi SAIKI, Akihiro KAGAWA, Akihisa SAITO, Kiyomi TANIYAMA The Journal of the Japanese Society of Clinical Cytology.2019; 58(3): 133. CrossRef
Lymphomas arising in the central nervous system (CNS) of immunocompromised hosts are most commonly non-Hodgkin’s lymphomas and are highly associated with Epstein-Barr virus (EBV). Here we report an autopsy case of EBV-associated CNS diffuse large B-cell lymphoma (DLBCL) in a host suffering from systemic lupus erythematosus who underwent immunosuppressive therapy. After autopsy, EBV-associated CNS DLBCL as well as pulmonary mixed aspergillosis and Pneumocystis jirovecii pneumonia were added to the cause of clinical manifestations of complicated pneumonia and cerebral hemorrhage in this immunocompromised patient. In conclusion, complex disease processes were revealed by autopsy in this case, indicating that the clinicopathological correlations observed through autopsy can improve our understanding of disease progression and contribute to the management of similar patients in the future.
Citations
Citations to this article as recorded by
Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review Takanori Ichikawa, Yasuhiro Shimojima, Dai Kishida, Tomoki Kaneko, Yoshiki Sekijima Rheumatology International.2021; 41(5): 1009. CrossRef
Colloid carcinoma, which is a very rare tumor of the uterine cervix, is composed of an excessive amount of mucus and a relative paucity of tumoral glandular cells within them. Herein, we report a rare case of colloid carcinoma of the cervix with adenocarcinoma in situ (AIS), intestinal and usual types, and endocervical adenocarcinoma (usual type) components. We also discuss the morphological and immunohistochemical characteristics of this tumor. A 51-year-old woman was referred to our outpatient clinic with the symptom of genital bleeding lasting for 5 months. She had a cervix surrounded by an irregular tumor with a diameter of 5 cm. The colloid carcinoma cells were positive for MUC2, MUC5AC, and cytokeratin (CK) 7, focal positive for CDX2, and negative for MUC6 and CK20. Also, the intestinal type AIS showed a similar staining pattern. Colloid carcinoma cells producing mucin showed an intestinal phenotype and AIS. The intestinal type can be considered as a precursor lesion of colloid carcinoma.
Cryptococcus neoformans is the most common microorganism found in cerebrospinal fluid (CSF) cytology and causes life-threatening infections in immunocompromised hosts. Although its cytomorphologic features in conventional smear cytology have been well described, those in liquid-based cytology have rarely been. A 73-year-old woman with diffuse large B-cell lymphoma presented with mental confusion and a spiking fever. To rule out infectious conditions, CSF examination was performed. A cytology slide that was prepared using the ThinPrep method showed numerous spherical yeast-form organisms with diameters of 4–11 μm and thick capsules. Occasional asymmetrical, narrow-based budding but no true hyphae or pseudohyphae were observed. Gomori methenamine silver staining was positive. Cryptococcosis was confirmed in blood and CSF through the cryptococcal antigen test and culture. Liquid-based cytology allows for a clean background and additional slides for ancillary testing, facilitating the detection of microorganisms in CSF specimens, particularly when the number of organisms is small.
Citations
Citations to this article as recorded by
Unraveling Capsule Biosynthesis and Signaling Networks in Cryptococcus neoformans Eun-Ha Jang, Ji-Seok Kim, Seong-Ryong Yu, Yong-Sun Bahn, Teresa R. O’Meara Microbiology Spectrum.2022;[Epub] CrossRef
Cerebrospinal fluid pleocytosis in immunocompromised patients: Can it be Cryptococcus Ridhi Sood, Ruchita Tyagi, Pavneet Selhi, Harpreet Kaur, Neena Sood Diagnostic Cytopathology.2020; 48(2): 164. CrossRef
Special Staining of the Liquid-Based Cytopathology Test in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients Yue Hu, Lin Zheng, Deng Pan, Lei Shao, Xianfa Xu, Yiming Yu, Qidong Zhuang, Zaichun Deng, Zhongbo Chen Canadian Respiratory Journal.2020; 2020: 1. CrossRef
Sensitivity of Cerebrospinal Fluid Cytology for the Diagnosis of Cryptococcal Infections Kelsey E McHugh, Melanie Gersey, Daniel D Rhoads, Gary W Procop, Yaxia Zhang, Christine N Booth, Charles D Sturgis American Journal of Clinical Pathology.2019; 151(2): 198. CrossRef
Cryptococcal Capsules in Cerebrospinal Fluid Visible on Hemocytometer Zen Kobayashi, Yuriko Hirota, Shuzo Shintani Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2018; 45(6): 700. CrossRef
Unexpected intraoperative finding of a hyalinizing cholecystitis in a patient with gallbladder calculi Klaudia Gjinoska, Andrej Nikolovski, Emil Stoicovski, Zan Mitrev Journal of Surgical Case Reports.2024;[Epub] CrossRef
Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know Camila Lopes Vendrami, Michael J. Magnetta, Pardeep K. Mittal, Courtney C. Moreno, Frank H. Miller RadioGraphics.2021; 41(1): 78. CrossRef
A simple method for diagnosing gallbladder malignant tumors with subserosa invasion by endoscopic ultrasonography Mitsuru Sugimoto, Hiroki Irie, Mika Takasumi, Minami Hashimoto, Yuka Oka, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Jun Nakamura, Tsunetaka Kato, Ryoichiro Kobashi, Yuko Hashimoto, Shigeru Marubashi, Takuto Hikichi, Hiromasa Ohi BMC Cancer.2021;[Epub] CrossRef
KRONİK KOLESİSTİTİN NADİR VE MALİGNİTE POTANSİYELİ YÜKSEK OLAN ALT TİPİ; HYALİNİZE KOLESİSTİT: OLGU SUNUMU Leymune PARLAK, Bahar MEMİŞ Balıkesir Medical Journal.2019; 3(3): 129. CrossRef